Kristina S. Boye

United States Valuation of EQ-5D-5L Health States Using an International Protocol

A. Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health · 2019 · 391 citations · Full text

Pharmacy, Educational Measurement, Health Assessment +16

Multi‐country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (<scp>CREED</scp>)

S.M. Babineaux, Dalia N. Toaima, Kristina S. Boye et al. · Diabetic Medicine · 2015 · 152 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Utilities and disutilities for attributes of injectable treatments for type 2 diabetes

Kristina S. Boye, Louis S. Matza, Kimberly N. Walter et al. · The European Journal of Health Economics · 2010 · 140 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States

V. Foos, N. Varol, Bradley Curtis et al. · Journal of Medical Economics · 2015 · 118 citations · Full text

Pharmacy, Economics, Pharmacoeconomics +17

Utilities and disutilities for type 2 diabetes treatment-related attributes

Louis S. Matza, Kristina S. Boye, Nicole Yurgin et al. · Quality of Life Research · 2007 · 115 citations

Pharmacy, Pharmacoeconomics, Cost-utility Analysis +13